The utility of plasma circulating cell-free messenger RNA as a biomarker of glioma: a pilot study.
Ita MI, Wang JH, Toulouse A, Lim C, Fanning N, O'Sullivan M, Nolan Y, Kaar GF, Redmond HP.
Ita MI, et al. Among authors: redmond hp.
Acta Neurochir (Wien). 2022 Mar;164(3):723-735. doi: 10.1007/s00701-021-05014-8. Epub 2021 Oct 13.
Acta Neurochir (Wien). 2022.
PMID: 34643804
Free PMC article.
Plasma ccfmRNAs and glioma-derived RNA were extracted and profiled. RESULTS: BCL2L1, GZMB, HLA-A, IRF1, MYD88, TLR2, and TP53 genes were significantly over-expressed in glioma patients (p < 0.001, versus control). ...
Plasma ccfmRNAs and glioma-derived RNA were extracted and profiled. RESULTS: BCL2L1, GZMB, HLA-A, IRF1, MYD88, TLR2, and TP53 genes w …